权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Protein O-GlcNAcylation in Regulatory T Cell Function

调节性 T 细胞功能中的蛋白 O-GlcNAc 酰化

基本信息

批准号：
10284929
负责人：
Hai-Bin Ruan
金额：
$ 47.97万
依托单位：
UNIVERSITY OF MINNESOTA
依托单位国家：
美国
项目类别：
财政年份：
2018
资助国家：
美国
起止时间：
2018-11-23 至 2023-10-31
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/10284929
关键词：
Acetylation Autoimmune Autoimmune Diseases Biological Process Cell Line Cell Lineage Cell physiology Cells Cellular biology Clinical Communities Data Development Disease Enzymes FOXP3 gene Face Genetic Transcription Graft Rejection Heterogeneity Homeostasis Human IL2 Signaling Pathway Immunotherapeutic agent Immunotherapy In Vitro Infection Inflammation Instruction Interleukin 2 Receptor Interleukin-2 Knock-out Link Malignant Neoplasms Mediating Metabolism Modeling Modification Molecular Mus Mutant Strains Mice O-GlcNAc transferase Pathway interactions Patients Phosphorylation Play Post-Translational Protein Processing Property Proteins Proteome Proteomics Receptor Activation Receptor Signaling Regulatory T-Lymphocyte Reporter Reporting Role Serine Signal Pathway Signal Transduction Stat5 protein Stimulus Syndrome T-Cell Receptor T-Lymphocyte Testing Therapeutic Threonine Tissues Translating Tyrosine Phosphorylation Ubiquitination calmodulin-dependent protein kinase II clinical implementation clinical practice effector T cell human disease immune self tolerance in vivo insight interest neoplastic cell novel organ transplant rejection programs transcription factor transcriptomics

项目摘要

PROJECT SUMMARY Regulatory T (Treg) cells, characterized by the expression of FOXP3, are a distinct lineage of T lymphocytes that control immunological self-tolerance and tissue homeostasis. These cells are associated with a multitude of human diseases, such as autoimmune disease, inflammation, organ transplant rejection, and some infections and cancers. The biomedical community has developed an intense interest in targeting Treg cells for immunotherapy; however, significant barriers, for example Treg-cell functional heterogeneity and instability, need to be surmounted in order to achieve clinical feasibility. The proposed study aims to understand a novel molecular mechanism that control the stability and function of Treg cells. Our preliminary data have found that a novel O-linked N-Acetylglucosamine (O-GlcNAc) protein modification, activated by T-cell receptor (TCR) signaling, is indispensable for the suppressive function of Treg cells. Treg cell-specific knockout of O-GlcNAc transferase (OGT), the enzyme catalyzing O-GlcNAcylation, does not affect Treg cell lineage specification but results in the development of an aggressive autoimmune syndrome in mice. O-GlcNAcylation modifies and stabilizes FOXP3 protein and transcriptomic analyses have revealed that IL-2/STAT5 signaling is suppressed in OGT-deficient Treg cells. Therefore, we hypothesize that TCR-initiated protein O-GlcNAcylation modulates FOXP3 and STAT5, thereby linking TCR and IL-2 signaling pathways, to regulate Treg cell homeostasis and effector function. In Aim 1, we hypothesize that loss of O-GlcNAcylation destabilizes FOXP3 protein, eliminating the suppressive function of Treg cells and converting Treg cells into effector T cells. We will determine whether O-GlcNAcylation counteracts ubiquitination to stabilize FOXP3 protein, thus maintaining the Treg identity. By generating FOXP3 mutant mice, in which O-GlcNAcylation is specifically abolished, we will test whether FOXP3 O-GlcNAcylation is required for the suppressive activity of Treg cells. In Aim 2, we propose to examine the effect of STAT5 O-GlcNAcylation on Treg cell suppressive function. We will test the hypothesis that O-GlcNAcylation controls IL-2-stimulated STAT5 activation in Treg cells and FOXP3 and STAT5 act cooperatively to mediate the effect of protein O-GlcNAcylation in Treg cell function. In Aim 3, we will identify the molecular link between TCR and O-GlcNAcylation in Treg cells. We will test the hypothesis that TCR signaling promotes protein O- GlcNAcylation and Treg cell suppressive activity in a Ca2+/CaMKII-dependent manner. Lastly, through unbiased O-GlcNAc proteomics, we will characterize TCR-regulated protein O-GlcNAcylation profile and identify potential complementary mechanisms for O-GlcNAc-mediated Treg cell function. The proposed study will stimulate the opening of a new avenue in therapeutics directed to activate and maintain Treg cells for immunotherapy.

项目总结